BridgeMD
Compares treatment options for Auditory Hallucination
Official title Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices
ClinicalTrials.gov ID: NCT05982158
What this study is testing
- What it's testing
- The aim of this study is to compare the effects of a new psychological therapy, Avatar Therapy, to the current standard therapy, Cognitive Behavioural Therapy (CBT), in improving outcomes in people living with psychotic disorders who have persisting experiences of hearing voices (auditory verbal hallucinations, AVHs).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Schizophrenia-related disorder or a mood disorder with psychotic symptoms diagnosis confirmed using the Structured Clinical Interview for DSM (SCID)
- Experiencing current auditory verbal hallucinations as measured by the Positive and Negative Syndrome Scale (PANSS) item P3 ≥ 4
- Auditory verbal hallucinations present for at least one year
- AVHs include significant negative content (PSYRATS item 6 ≥ 2) and/or AVHs are distressing (PSYRATS item item 9 ≥ 2)
- Current treatment with antipsychotic medication, or has been treated with antipsychotic medication in the past, with at least two different...
You likely can't join if
- Auditory verbal hallucinations attributable to a primary substance use disorder or organic disorder
- Estimated full scale IQ \< 70 (using the Test of Premorbid Functioning, TOPF)
- Within the last month or planned at the time of intake: a change of antipsychotic medication,
- Current or within the past 3 months receipt of individual psychological therapy for hearing voices, or receipt of electro-convulsive therapy or other...
- AVHs in a language not spoken by the therapists.
See the full eligibility criteria
- Schizophrenia-related disorder or a mood disorder with psychotic symptoms diagnosis confirmed using the Structured Clinical Interview for DSM (SCID)
- Experiencing current auditory verbal hallucinations as measured by the Positive and Negative Syndrome Scale (PANSS) item P3 ≥ 4
- Auditory verbal hallucinations present for at least one year
- AVHs include significant negative content (PSYRATS item 6 ≥ 2) and/or AVHs are distressing (PSYRATS item item 9 ≥ 2)
- Current treatment with antipsychotic medication, or has been treated with antipsychotic medication in the past, with at least two different antipsychotic compounds, and these have been discontinued due to insufficient...
- Access to the internet and a computer or other device on which videoconferencing software can be used
- Sufficient fluency in English for meaningful participation
- Age 18 or over
- Ability to give informed consent
- Auditory verbal hallucinations attributable to a primary substance use disorder or organic disorder
- Estimated full scale IQ \< 70 (using the Test of Premorbid Functioning, TOPF)
- Within the last month or planned at the time of intake: a change of antipsychotic medication,
- Current or within the past 3 months receipt of individual psychological therapy for hearing voices, or receipt of electro-convulsive therapy or other brain stimulation treatment;
- AVHs in a language not spoken by the therapists.
The study team makes the final eligibility decision.
Where it's taking place
- Hawthorn, Victoria, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hawthorn, Victoria, Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.